Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
May guide antifibrotic trial design in cardiorenal syndromes; leaves open whether such strategies improve outcomes.
Zannad et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: